Mq. Wang et al., Portal-systemic myelopathy after transjugular intrahepatic portosystemic shunt creation: Report of four cases, J VAS INT R, 12(7), 2001, pp. 879-881
The authors attempted to describe the clinical manifestations of portal-sys
temic myelopathy (PSM) after transjugular intrahepatic portosystemic shunt
(TIPS) creation. PSM was developed in four of 212 (1.89%) patients who unde
rwent TIPS procedures in our hospital. Three men and one woman, ranging in
age from 41 to 56 years, with a history of posthepatitis cirrhosis and recu
rrent bleeding from gastroesophageal varices had intrahepatic shunts create
d with 10-mm-diameter Wallstents. Shunt patency was confirmed by color Dopp
ler ultrasonography (US) in each patient after TIPS creation. Progressive s
pastic paraparesis involving the lower extremities occurred between 5 weeks
and 5 months after TIPS creation in the four patients. Neurologic examinat
ion showed evidence of spasticity in all cases, with ankle clonus, extensor
plantar responses, and lower extremity hyperreflexia. All sensory modaliti
es remained intact. Cytologic examination of cerebrospinal fluid from each
patient was normal. There was no evidence of spinal cord compression on the
imaging studies. PSM is a rare syndrome that includes spastic paraparesis
with intact sensation. Initially noted in patients who have undergone surgi
cal placement of a portacaval shunt, it also may occur after TIPS creation.